Condition (MeSH)
Slipped Capital Femoral Epiphyses
ClinicalTrials.gov lists 19 trials for Slipped Capital Femoral Epiphyses or a narrower condition beneath it. DePuy International has the most among industry and government lead sponsors, with 13.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
19 of the 19 trials are tagged with Slipped Capital Femoral Epiphyses itself; the rest are tagged with a narrower condition beneath it.
When did Slipped Capital Femoral Epiphyses trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2008 | 1 |
| 2007 | 1 |
| 2006 | 4 |
| 2004 | 2 |
| 2003 | 3 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Slipped Capital Femoral Epiphyses trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 11 |
| Not applicable | 2 |
| Observational | 4 |
How many Slipped Capital Femoral Epiphyses trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Completed | 3 |
| Terminated | 11 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Slipped Capital Femoral Epiphyses trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| DePuy International | 13 |
| Zimmer Biomet | 2 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Observational | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Slipped Capital Femoral Epiphyses? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Slipped capital femoral epiphysis in children younger than 10 years old: clinical characteristics and efficacy of physeal-sparing procedures. | Journal of pediatric orthopedics. Part B | 2018 | Yes |
| Intraoperative Monitoring of Epiphyseal Perfusion in Slipped Capital Femoral Epiphysis. | The Journal of bone and joint surgery. American volume | 2016 | Yes |
| Delayed Slipped Capital Femoral Epiphysis After Treatment of Femoral Neck Fracture in Children. | Clinical orthopaedics and related research | 2015 | Yes |
| The Locking Compression Paediatric Hip Plate: technical guide and critical analysis. | International orthopaedics | 2012 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Epiphysiolysis of the hip | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Epiphysiolysis of the hip | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Epiphysiolysis of the hip | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Epiphysiolysis of the hip | 399329 | Exact | Orphadata Science knowledge files, Product 1 |
| Epiphysiolysis of the hip | 399329 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.